2025 ARC Award for Advancing Analytical Characterization of Peptide and Protein Therapeutics for Incretin and Related Pathway Targets
Applications under review
Award Focus Topic:
Advancing Analytical Characterization of Peptide and Protein Therapeutics for Incretin and Related Pathway Targets.
Additional Information:
- Proposals incorporating novel analytical approaches and automation of workflows to enhance the development, characterization, and quality of these compounds are encouraged. Analytical technologies that incorporate AI/ML are of interest.
- Please note that this opportunity is exclusively focused on the analytical characterization of peptide- and protein-based therapeutics. Applications involving small molecule therapeutics will not be considered.
Institution and Applicant eligibility
- Institution must be a degree-granting academic or a non-profit research institution.
- Applicant must hold a tenure-tracked faculty position and be authorized to serve as a principal investigator for research contracts and principal advisor of doctoral candidates at the institution.
Award Details
- Research projects should be scoped for a 3-year period with a total requested budget up to $500K (USD). Cash award is provided to the institution in the name of the awardee, in equal annual installments over the funding period. Awards have no deliverables and must be free of overhead or other fees.
- Awardee will receive an engraved plaque commemorating award, presented in a
suitable ceremony. - Awardee will be invited to visit and present research seminar at Agilent site
(expenses covered). - Awardee will be featured on ARC website.
Key Dates
- March 24, 2025 - Call for Applications begins
- April 30, 2025 - Submission Deadline
- September 1, 2025 - Winner announced on ARC website